EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieStudienprotokollOpen Access · CC BY 4.0

Early versus delayed trial without catheter in men with Acute urinary retention - Study Protocol for a dutch national randomized trial

Liselot L A Ribbert iD, Nadine A M van Merode iD, Marco H Blanker iD, Michelle M A Kip iD, Ingrid M Nijholt iD, Lambertus P W Witte iD, RELIEF Study Group

PLOS One · 06.08.2026 · 21 (8) · e0354879

DOI: 10.1371/journal.pone.0354879 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift PLOS One, online erschienen am 06.08.2026. Verfasst von Liselot L A Ribbert und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Primary and Long-term Care, Cure and Care in the Community Context (FOUR-C)-research Program, University Medical Center Groningen (UMCG…. Hauptthemen laut MEDLINE: Urinary Catheterization, Urinary Retention, Randomized Controlled Trials as Topic. Die Arbeit nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: ZonMw.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Acute urinary retention (AUR) is a burdensome urological emergency, often caused by benign prostatic obstruction. Standard management includes transurethral catheterization, alpha-blocker therapy, and a trial without catheter (TWOC) to assess spontaneous voiding. Despite the high incidence of AUR, the optimal catheter duration prior to TWOC remains uncertain. Evidence is limited, guideline recommendations are largely expert-based, and catheter duration varies widely in practice. Prolonged catheterization may increase morbidity and discomfort, whereas earlier removal may raise concerns regarding recurrent retention.

Methods

RELIEF is a pragmatic, multicenter, randomized non-inferiority trial comparing TWOC on day 3 versus TWOC on day 14 in men with AUR. All participants undergo transurethral catheterization and receive alpha-blocker therapy prior to randomization. Primary outcome is TWOC success, defined as a voided volume ≥100 mL and post-void residual ≤200 mL. The primary analysis follows a per-protocol approach, with a complementary intention-to-treat analysis to confirm non-inferiority. Secondary outcomes include recurrent retention, catheter-related complications, patient-reported symptoms and quality of life, and cost-effectiveness from healthcare and societal perspectives over 18 months. In parallel, a qualitative substudy using semi-structured interviews with healthcare professionals aims to explore the determinants underlying current practice variation, as well as the perceived barriers and facilitators for the sustainable implementation of a standardized TWOC strategy in future clinical practice.

Discussion

By comparing two catheterization intervals already applied in routine care and combining clinical, patient-reported, economic, and implementation outcomes, RELIEF is designed to generate directly applicable evidence on TWOC timing after AUR. The results are expected to support guideline refinement and improve consistency of care.

Trial registration

WHO ICTRP primary registry, identifier NL-OMON57836. Registered on February 7, 2025.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Urinary CatheterizationUrinary RetentionRandomized Controlled Trials as TopicAgedHumansMaleMiddle AgedAcute DiseaseCost-Benefit AnalysisNetherlandsQuality of LifeTime FactorsTreatment Outcome

Autor:innen und Institutionen

  • Department of Primary and Long-term Care, Cure and Care in the Community Context (FOUR-C)-research Program, University Medical Center Groningen (UMCG), Groningen, The Netherlands.
  • Department of Urology, Isala Clinics, Zwolle, The Netherlands.
  • Department of Urology, Maastricht University Medical Center+, Maastricht, The Netherland.
  • Department of Health Technology & Services Research, Faculty of Behavioral Management and Social Sciences, Technical Medical Centre, University of Twente, Enschede, The Netherlands.

ORCID-Profile: Liselot L A Ribbert, Nadine A M van Merode, Marco H Blanker, Michelle M A Kip, Ingrid M Nijholt, Lambertus P W Witte

Förderung

  • ZonMw

Zitieren

APA

Ribbert, L. L. A., van Merode, N. A. M., Blanker, M. H., Kip, M. M. A., Nijholt, I. M., Witte, L. P. W., & RELIEF Study Group (2026). Early versus delayed trial without catheter in men with Acute urinary retention - Study Protocol for a dutch national randomized trial. PLOS One, 21(8), e0354879. https://doi.org/10.1371/journal.pone.0354879

Vancouver

Ribbert LLA, van Merode NAM, Blanker MH, Kip MMA, Nijholt IM, Witte LPW, et al. Early versus delayed trial without catheter in men with Acute urinary retention - Study Protocol for a dutch national randomized trial. PLOS One. 2026;21(8):e0354879. doi:10.1371/journal.pone.0354879

BibTeX
@article{Ribbert2026,
  author = {Ribbert, Liselot L A and van Merode, Nadine A M and Blanker, Marco H and Kip, Michelle M A and Nijholt, Ingrid M and Witte, Lambertus P W and RELIEF Study Group, RELIEF Study Group},
  title = {Early versus delayed trial without catheter in men with Acute urinary retention - Study Protocol for a dutch national randomized trial},
  journal = {PLOS One},
  year = {2026},
  volume = {21},
  number = {8},
  pages = {e0354879},
  doi = {10.1371/journal.pone.0354879}
}
Kostenlos starten →